CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver.

Increased de novo lipogenesis (DNL) in white adipose tissue is associated with insulin sensitivity. Under both Normal-Chow-Diet and High-Fat-Diet, mice expressing a kinase inactive Cyclin-dependent kinase 6 (Cdk6) allele (K43M) display an increase in DNL in visceral white adipose tissues (VAT) as compared to wild type mice (WT), accompanied by markedly increased lipogenic transcriptional factor Carbohydrate-responsive element-binding proteins (CHREBP) and lipogenic enzymes in VAT but not in the liver. Treatment of WT mice under HFD with a CDK6 inhibitor recapitulates the phenotypes observed in K43M mice. Mechanistically, CDK6 phosphorylates AMP-activated protein kinase, leading to phosphorylation and inactivation of acetyl-CoA carboxylase, a key enzyme in DNL. CDK6 also phosphorylates CHREBP thus preventing its entry into the nucleus. Ablation of runt related transcription factor 1 in K43M mature adipocytes reverses most of the phenotypes observed in K43M mice. These results demonstrate a role of CDK6 in DNL and a strategy to alleviate metabolic syndromes. © 2024. The Author(s).

Citation

Alexander J Hu, Wei Li, Calvin Dinh, Yongzhao Zhang, Jamie K Hu, Stefano G Daniele, Xiaoli Hou, Zixuan Yang, John M Asara, Guo-Fu Hu, Stephen R Farmer, Miaofen G Hu. CDK6 inhibits de novo lipogenesis in white adipose tissues but not in the liver. Nature communications. 2024 Feb 05;15(1):1091

Mesh Tags

Substances

PMID: 38316780

search → result